Enrique Poradosu

2023

In 2023, Enrique Poradosu earned a total compensation of $1.6M as Chief Scientific & Business Officer at Nuvectis Pharma, a 61% increase compared to previous year.

Compensation breakdown

Bonus$250,750
Salary$454,750
Stock Awards$857,900
Total$1,563,400

Poradosu received $857.9K in stock awards, accounting for 55% of the total pay in 2023.

Poradosu also received $250.8K in bonus and $454.8K in salary.

Rankings

In 2023, Enrique Poradosu's compensation ranked 738th out of 2,785 executives tracked by ExecPay. In other words, Poradosu earned more than 73.5% of executives.

ClassificationRankingPercentile
All
738
out of 2,785
74th
Division
Manufacturing
429
out of 1,525
72nd
Major group
Chemicals And Allied Products
294
out of 864
66th
Industry group
Drugs
288
out of 827
65th
Industry
Pharmaceutical Preparations
190
out of 592
68th
Source: SEC filing on April 29, 2024.

Poradosu's colleagues

We found two more compensation records of executives who worked with Enrique Poradosu at Nuvectis Pharma in 2023.

2023

Ron Bentsur

Nuvectis Pharma

Chief Executive Officer

2023

Shay Shemesh

Nuvectis Pharma

Chief Development & Operations Officer

News

You may also like